Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Lenskart Solutions IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size 4010.4 Cr
Profile
Price Range 382  to  402 per share
Profile
Min Investment ₹402
Profile
Lot Size 1
Profile
Face Value ₹2
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

We are a technology-driven eyewear company with integrated operations spanning designing, manufacturing, branding and retailing of eyewear products. We primarily sell prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories. India is our largest market, and according to the Redseer Report, we are the largest seller of prescription eyeglasses in terms of volumes sold in India in Financial Year 2025. Leveraging our experience and capabilities in India, we have expanded into select international markets including Japan, Southeast Asia and the Middle East. We are India’s largest, and in Asia, are amongst the two largest, organized retailers of prescription eyeglasses in terms of B2C eyeglasses sales volumes during the Financial Year 2025, according to the Redseer Report. Read More

Basic Info

Face Value 2 per share

Price 382  to  402 per share

P/E (x) 223.3

Sales( Cr.) 6653

PAT( Cr.) 297

EPS 1.8

Draft Prospectus

Exchange BSE-NSE

Promoter

Company Promoters

Peyush Bansal Neha Bansal Amit Chaudhary Sumeet Kapahi

Pre Issue Share Holding 19.9%

Post Issue Share Holding 17.57%

Listing Details:

Listing Price: 390

Listing Gain: -3.08%

Current Price: 523.9

Gain On Issue: 523.9 | 0%

GMP: 10

GMP %: 2.5 %

IPO Tentative Timetable

Opening Date Oct 31, 2025
Closing Date Nov 04, 2025
Allotment Nov 05, 2025
Refund Nov 06, 2025
Delivery of Shares Nov 06, 2025
Listing Date Nov 07, 2025

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 37 14,874
Retail (Max) 13 481 193,362
S-HNI (Min) 14 518 208,236
S-HNI (Max) 67 2479 996,558
B-HNI (Min) 68 2516 1,011,432

Objective of the Issue

• Capital expenditure towards set-up of new CoCo stores in India • Expenditure for lease/rent/license agreements related payments for our CoCo stores operated by our Company in India • Investing in technology and cloud infrastructure • Brand marketing and business promotion expenses for enhancing brand awareness • Unidentified inorganic acquisitions and general corporate purposes.

Issue

Category Nos Bid Bid (x)
QIB 54201608 2186808632 40.3x
NII 27100803 493958103 18.2x
Retail 18067202 136136320 7.5x
EMP 391644 1942426 5x
Total 99761257 2818845481 28.3x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Lenskart Solutions Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 95 158 292 474 900 905 1503 3788 5428 6653
Other Income 4 22 16 11 69 127 116 140 182 357
Total Income 99 180 309 486 970 1032 1618 3928 5610 7009
Total Expenditure 209 438 418 503 933 952 1617 3524 4754 5676
Operating Profit -110 -258 -110 -17 37 80 1 404 856 1333
Interest 0 0 0 0 4 7 23 83 124 147
Depreciation 4 6 8 14 27 39 85 418 672 797
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -114 -264 -118 -32 6 29 -108 -101 59 385
Provision for Tax 0 0 0 0 0 0 0 -37 69 88
Profit After Tax -114 -264 -118 -32 6 29 -108 -64 -10 297
Adjustments 0 0 0 0 0 0 6 -4 -7 -2
Profit After Adjustments -114 -264 -118 -32 6 29 -102 -68 -17 296
Adjusted Earnings Per Share -4.7 -13.6 -1.7 -0.3 0.1 0.4 -1.3 -0.9 -0.2 3.8

Lenskart Solutions Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 108 -976 356 325 2362 2392 2948 5474 5649 6099
Minority's Interest 0 0 0 0 0 0 0 96 107 107
Borrowings 1 1395 0 0 0 0 0 574 268 212
Other Non-Current Liabilities 1 9 9 9 52 158 386 1731 1952 2103
Total Current Liabilities 37 37 54 110 170 251 366 1588 1510 1869
Total Liabilities 147 464 419 444 2583 2802 3700 9462 9487 10390
Fixed Assets 31 37 82 88 155 232 257 4388 4535 6231
Other Non-Current Assets 8 23 25 39 376 336 1491 1161 1515 528
Total Current Assets 109 405 312 318 2052 2233 1952 3913 3437 3630
Total Assets 147 464 419 444 2583 2802 3700 9462 9487 10390

Lenskart Solutions Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1 1 3 9 24 6 6 292 220
Cash Flow from Operating Activities -141 -161 -144 -32 -89 -117 -183 95 487 1231
Cash Flow from Investing Activities 24 -262 147 38 -1915 114 -421 -2976 159 -266
Cash Flow from Financing Activities 117 424 -1 -0 2019 -16 604 2777 -722 -535
Net Cash Inflow / Outflow 0 0 2 6 16 -18 0 -105 -76 430
Closing Cash & Cash Equivalent 1 1 3 9 24 6 6 292 220 654

Lenskart Solutions Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -4.73 -13.62 -1.74 -0.31 0.08 0.38 -1.34 -0.89 -0.23 3.83
CEPS(Rs) -4.58 -13.31 -1.62 -0.17 0.43 0.89 -0.29 4.63 8.59 14.18
DPS(Rs) 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 4.27 -50.45 5.23 3.15 30.76 31.08 38.28 71.24 70.93 76.58
Core EBITDA Margin(%) -121.12 -175.94 -43.22 -6.06 -3.6 -5.19 -7.63 6.96 12.42 14.67
EBIT Margin(%) -120.34 -165.96 -40.34 -6.65 1.15 4.02 -5.62 -0.47 3.36 8
Pre Tax Margin(%) -120.65 -166.1 -40.4 -6.66 0.7 3.19 -7.17 -2.67 1.09 5.79
PAT Margin (%) -120.65 -166.1 -40.4 -6.66 0.7 3.19 -7.17 -1.68 -0.19 4.47
Cash Profit Margin (%) -116.86 -162.31 -37.63 -3.7 3.66 7.52 -1.49 9.34 12.2 16.44
ROA(%) -77.48 -86.27 -26.72 -7.31 0.42 1.07 -3.32 -0.97 -0.11 2.99
ROE(%) -110.72 0 0 -9.33 0.47 1.23 -4.07 -1.52 -0.19 5.23
ROCE(%) -103.96 -99.74 -30.43 -9.26 0.77 1.52 -3.14 -0.38 2.91 8.45
Receivable days 200.97 148.74 145.8 107.7 61.69 42.82 14.25 17.66 20.93 12.82
Inventory Days 4.63 4.46 5.49 35.8 39.13 65.05 54.53 40.64 43.69 48.54
Payable days 124.62 74.68 60.48 80.61 82.23 121.12 92.88 106.08 118.83 114.17
PER(x) 0 0 0 0 0 0 0 0 0 0
Price/Book(x) 0 0 0 0 0 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.08 8.7 -0.03 -0.11 -0.11 -0.26 -0.03 -0.01 -0.02 -0.03
EV/Core EBITDA(x) -0.07 -5.35 0.08 3.04 -2.63 -2.93 -40.01 -0.09 -0.15 -0.15
Net Sales Growth(%) 0 67.25 84.44 62.37 89.79 0.57 65.99 152.08 43.29 22.57
EBIT Growth(%) 0 -131.4 55.27 73.27 132.86 250.8 -332.15 78.79 1119.86 191.4
PAT Growth(%) 0 -131.01 55.25 73.26 120.02 357.57 -472.77 40.87 84.07 3028.3
EPS Growth(%) 0 -188.12 87.21 82.26 126.86 356.27 -453.47 33.55 74.54 1791.13
Debt/Equity(x) 0.01 -1.43 0 0 0 0.01 0.01 0.17 0.09 0.06
Current Ratio(x) 2.95 11.02 5.74 2.89 12.1 8.89 5.33 2.46 2.28 1.94
Quick Ratio(x) 2.91 10.94 5.62 2.1 11.47 8.02 4.7 2.08 1.82 1.36
Interest Cover(x) -389.03 -1161.7 -760.92 -670.87 2.56 4.89 -3.6 -0.21 1.48 3.63
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 23% 64% 49% 0%
Operating Profit CAGR 56% 1001% 105% 0%
PAT CAGR 0% 0% 118% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 5% 1% 0% -12%
ROCE Average 8% 4% 2% -23%

Company Contact Information

Lenskart Solutions Ltd.

Preeti Gupta

+91 124 429 3191

compliance.officer@lenskart.com

Plot No. 151 Okhla Industrial Estate Phase I I I

IPO Lead Manager(s)

Lenskart Solutions Ltd.

Kotak Mahindra Capital Co Ltd

Morgan Stanley India Co Pvt Ltd

Avendus Capital Pvt Ltd.

Citigroup Global Markets India Pvt Ltd.

Axis Capital Ltd.

Intensive Fiscal Services Pvt Ltd

Registrar Info

Lenskart Solutions Ltd.

MUFG Intime India Pvt Ltd.

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai (Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra

+91 810 811 8484

91-022-49186060

rnt.helpdesk@in.mpms.mufg.com

https://in.mpms.mufg.com/

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!